China (Mainland)
Premiumsupplier
BIBW2992 DiMaleate （850140-73-7） CAS NO.850140-73-7
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T,MoneyGram
- Product Details
Keywords
- BIBW2992 DiMaleate
- 99% BIBW2992 DiMaleate
- BIBW2992 DiMaleate Manufacturer
Quick Details
- ProName: BIBW2992 DiMaleate （850140-73-7）
- CasNo: 850140-73-7
- Molecular Formula: C32H33ClFN5O11
- Appearance: white solid
- Application: Afatinib dimaleate (Tovok; BIBW2992; G...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Transportation: By Sea/Air/Courier
- LimitNum: 10 Gram
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
BIBW2992 DiMaleate
| CAS: | 850140-73-7 |
| MF: | C32H33ClFN5O11 |
| MW: | 718.0827232 |
| Appearance: | White solid |
| Assay: | 99% |
| Description: Afatinib dimaleate (Tovok; BIBW2992; Gilotrif) is a salt form of Afatinib. Afatinib is a second-generation, orally administered, irreversible inhibitor of the ErbB family of tyrosine kinases. | |
| Uses: A maleate salt obtained by combining afatinib with two molar equivalents of maleic acid. Used for the first-line treatment of patients with metastatic non-small cell lung cancer. | |
